TW202136690A - A sterilization, disinfection, sanitization, or decontamination system and method - Google Patents

Abstract

A sterilization, disinfection, sanitization, or decontamination system having a chamber defining a region, and a generator for creating a free radical effluent with reactive oxygen, nitrogen, and other species and/or a vaporizer. A closed loop circulating system without a free-radical destroyer is provided for supplying the mixture of free radicals from the generator mixed with the hydrogen peroxide solution in the form of the effluent to the chamber. The system is used in sterilizing, disinfecting, sanitizing, or decontaminating items in the chamber or room and, with a wound chamber, in treating wounds on a body.

Description

System and method for inhibiting virus and bacteria disintegration in chamber space

The present invention relates to a system and method for inhibiting virus and bacteria disintegration in a room space, in particular to a virus and bacteria disintegration inhibition technology that can achieve indoor sterilization, purify the air, and greatly reduce the probability of virus infection.

In recent years, local or global epidemic viruses have been raging around the world frequently, such as new influenza viruses, enteroviruses, dengue viruses, and other unknown viruses. The above-mentioned epidemic viruses not only cause human respiratory diseases, but also Attacking the human kidney, liver and other organs, it is obvious that all kinds of viruses have been threatening human life and health. In addition, the Wuhan Novel Coronavirus (New Coronavirus for short) was first discovered in Wuhan, China in December 2019. Since the outbreak of the epidemic, so far, there have been more than 200,000 confirmed cases in more than 100 countries, and more than 10,000 deaths have been caused. The mortality rate is as high as 3 to 4%. Under serious threats, therefore, how to strengthen personal hygiene protection measures and avoid the threat of mass infection has become a challenge and issue that people in today's society must face.

In order to solve the above problems, Mr. Lin Shiming, the director of the Institute of Medical Devices and Medical Imaging of National Taiwan University School of Medicine, successfully developed a patent as shown in Invention No. I488661 "Substances and Methods for Disintegrating and Inhibiting the Proliferation of Viral and Bacterial Infections." It uses 2-(10-hydrosulfanyldecyl)propanedi Acid (2-(10-mercaptodecyl)malonic acid) or its salts to destroy such as human influenza virus, avian influenza virus, swine influenza virus, human pig or human poultry genetic recombinant influenza virus, and enterovirus without mantle; but The active agent made in this patent is mainly for external use to protect the above-mentioned viruses, such as 2-(10-mercaptodecyl)malonic acid (2-(10-mercaptodecyl)malonic acid) or its salt This type of application is applied to protective function related products, such as masks, protective clothing, and other related air filter materials. It can be seen that this patent can only prevent infection of the above-mentioned viruses, because this patent has not been seen to be applied to air supply through atomization. Until the indoor space achieves the effect of inhibiting the disintegration of viruses and bacteria, it cannot effectively achieve the effect of sterilization and purification of the air in the indoor space.

In addition, among the methods of indoor sterilization, most people will buy air purifiers to purify the indoor air. Some air purifiers also emphasize that they can generate negative ions to achieve fresh air and sterilization effects; but According to a recent study by National Taiwan University, negative ions can only achieve antibacterial effects at most, but cannot directly sterilize. Moreover, many negative ion home appliances including air purifiers will also produce ozone harmful to the human body at the same time. Once the negative ion concentration is too high, It may cause bronchitis and even cause the possibility of pneumonia, so the air purifiers sold in the market do not have the effect of indoor sterilization.

In addition, some hospitals will install several UV lamps on the ceiling of the hospital, and use the ultraviolet light waves emitted by the ultraviolet lamps to achieve the sterilization effect; however, the ultraviolet light waves can cause damage to the naked eyes and skin of the human body. Therefore, most hospitals choose to The UV lamps are turned on when there is no one to avoid harm to the human body, which will limit the sterilization timing of the UV lamps to a certain extent, which will cause inconvenience and troubles in the use of indoor sterilization. In view of the improper design of the isolation cabin on the Diamond Princess cruise ship and the lack of indoor sterilization equipment, the number of people infected with new coronary pneumonia has been out of control. Therefore, how to develop an isolation room or cabin at this stage? The indoor sterilization technology that sterilizes the room quickly and effectively to purify the air has become a technical topic that the industry in the related technical field urgently wants to solve and challenge.

In view of this, the aforementioned known technology is indeed not perfect, and there is still a need for improvement; the reason is that the inventors are actively working on research and development. After continuous hard work and trial experiments, they finally developed a new technology in today’s severe epidemic. The present invention can effectively sterilize the isolated indoor space.

The first objective of the present invention is to provide a system and method for inhibiting the disintegration of viruses and bacteria in a compartment space, which is mainly to atomize a bactericidal medicine into a mist-like medicine, and then uniformly transport the medicine to the compartment space through a blower. Solve the viruses or bacteria that exist in the room space, and can be applied to isolation wards, isolation cabins (including cruise ships, airplanes, trains, MRT carriages, and cars to accommodate people or cabins for people to lie down and sleep. ), rooms and isolation tents and other accommodation spaces to achieve indoor sterilization, air purification and greatly reduce the probability of virus infection. The technical means to achieve the first objective of the present invention is to use a medicament atomization device to atomize the medicament into a mist-like medicament, and use the air blowing device to transport the aerosolized medicament atomized by the medicament atomization device into the chamber space through the air supply channel. In order to disintegrate the virus or bacteria existing in the chamber space through the mist-like medicament in the chamber space.

The second object of the present invention is to provide a system and method for inhibiting virus and bacteria disintegration in a chamber space with several isolation and sterilization fog screens, which are mainly formed by forming a plurality of fog-like agents to isolate adjacent hospital beds. , And use several isolation and sterilization fog screens to produce sterilization and isolation to reduce the chance of cross-infection of patients in the same indoor space. The technical means to achieve the second objective of the present invention is to use a medicament atomization device to atomize the medicament into a mist-like medicament, and use the air supply device to pass through The aerosol medicament atomized by the medicament atomization device is transported into the chamber space through the air supply channel, so that the aerosol medicament in the chamber space can disintegrate the viruses or bacteria existing in the chamber space. Wherein, a plurality of nozzles arranged in rows on at least one duct of the at least one air supply channel are used to deliver the mist-like medicine into the chamber space to form at least one medicine mist curtain, so that the at least one medicine mist curtain surrounds the container. At least one side of at least one patient in the room space.

The third object of the present invention is to provide a system and method for capturing virus and bacteria in the chamber space or the air supply or return air channel for the concentrated and effective disintegration of the medicine. The technical means to achieve the third objective of the present invention is mainly to install at least one electrostatic cloth layer in the chamber space and/or the air supply channel and/or the return air channel, and use the electrostatic cloth layer to capture that it is or has been in the chamber space The virus and/or bacteria can be used to disperse the sprayed medicine to disintegrate the viruses and/or bacteria that have been attached to the electrostatic cloth layer.

The fourth object of the present invention is to provide a system and method for promoting the inhibitory effect of the drug on the disintegration of viruses and/or bacteria through environmental condition control. The technical means to achieve the fourth objective of the present invention is mainly to install matching heaters and coolers, or to install a pressurizer to increase the temperature of the air in the chamber space and/or the air supply channel and/or the return air channel , Or increase the air pressure in the chamber space to promote the effectiveness of the aerosol medicine to disintegrate viruses and/or bacteria.

10: Medicament atomization device

20: Air supply device

30: Room space

31: Air inlet

40: Air supply channel

41: Catheter

42: Nozzle

50: heater

51: filter

52: cooler

53: Electrostatic cloth layer

60: Return air device

61: Return air channel

62: Connecting pipeline

70: Concentration data generation unit

71: intake valve

72: exhaust valve

73: Return air valve

74: Control Module

Figure 1 is a schematic diagram of the first specific embodiment and use of the basic features of the present invention.

Figure 2 is a schematic diagram of the connection between the electrical circuit and the fluid pipeline of the present invention.

Fig. 3 is a schematic diagram of the first action implementation of the fluid pipeline of the present invention.

Fig. 4 is a schematic diagram of the second action implementation of the fluid pipeline of the present invention.

Fig. 5 is a schematic diagram of the third action implementation of the fluid pipeline of the present invention.

FIG. 6 is a schematic diagram of a specific architecture implementation of the second embodiment of the present invention.

Fig. 7 is a schematic diagram of a second specific embodiment and usage of the basic features of the present invention.

In order for your reviewer to further understand the overall technical features of the present invention and the technical means to achieve the purpose of the invention, specific examples and drawings are used to illustrate in detail as follows:

Please refer to Figures 1 and 7, in order to achieve the first objective of the present invention, a basic specific embodiment is that at least one medicament atomization device 10 is used to atomize medicament into aerosol medicament, and at least one air supply device 20 is used to The atomized medicament atomized by at least one medicament atomization device 10 is transported and supplied into a compartment space 30 (including isolation wards, isolation cabins (cruise, airplane, train, MRT carriage and automobile) through at least one air supply channel 40 It is used to accommodate people or sleep in cabins), rooms and isolation tents, etc. compartment space 30), and then disintegrate and exist in the compartment space 30 with a predetermined concentration of aerosol medicine in the compartment space 30. Viruses and/or bacteria inside. The example of the diagram shown in FIG. 1 is that the medicine atomization device 10, the air blowing device 20, and the air blowing channel 40 are designed into a large system similar to an air conditioner. The example shown in Figure 7 is that the medicament atomization device 10, the air supply device 20 and the air supply channel 40 are arranged on a housing and designed as a small body (portable or mobile) for the user to place in the chamber space. Within 30, it can especially be placed close to the bed.

Please refer to a preferred application embodiment shown in FIG. 1, in which at least one air supply channel 40 is connected to at least one air inlet 31 of the chamber space 30, and at least one patient in the chamber space 30 is located for a long time. The location (for example, the patient’s bed) within 4 meters, is used to blow the sprayed medicament close to the at least one patient, and immediately disintegrate the virus and/or discharged from the body of the at least one patient Or bacteria, so as to improve the disintegration efficiency and reduce the number of viruses and/or bacteria in other areas of the chamber space.

Please refer to FIGS. 1 to 2 and FIG. 6, in order to achieve the second objective of the present invention, a specific embodiment uses at least one medicament atomizing device 10 to atomize the medicament into aerosol medicament, and at least one air supply device 20 The aerosol medicament atomized by at least one medicament atomization device 10 is transported and supplied into a chamber space 30 through at least one air supply channel 40, and then the aerosol medicament in the chamber space 30 disintegrates and exists in the chamber space 30 Viruses and/or bacteria inside. The main part of the specific implementation of this embodiment is that a plurality of nozzles 42 arranged in rows on at least one duct 41 of at least one air supply channel 40 are used to deliver the mist-like medicine into the chamber space 30 to form at least one medicine mist screen. , So that at least one medicine mist curtain is arranged on at least one side of at least one patient in the chamber space 30 (preferably at least one medicine mist curtain surrounds at least one patient). As shown in Figure 6, a plurality of medicine mists are located between the two hospital beds to isolate the two hospital beds to avoid cross-sensing situations.

Please refer to the embodiment shown in FIG. 1, the new air located outside the chamber space 30 is first heated by at least one heater 50 and filtered by at least one filter 51, and then mixed with the mist-like medicament and sent into the chamber space 30. . The heating by the heater 50 promotes the effect of disintegrating viruses and/or bacteria existing in the chamber space 30. The filter 51 is used to filter impurities or pollutants in the air, after purifying the air, to enhance the disintegration efficiency of the mist-like agent against viruses and/or bacteria.

Please refer to the embodiment shown in FIG. 1, at least one filter 51 of the return air device 60 is used to filter the part of the air mixed with the mist-like medicament discharged from the chamber space 30 to recover the air, and mix the recovered air to The fresh air is sent into the chamber space 30 by the air blowing device 20 together.

As shown in the application embodiment shown in Figure 5, when the mist-like medicament in the chamber space 30 reaches a predetermined concentration, the mist-like medicament is continuously supplied to the chamber space 30, and the air supply device 20 will be located in the chamber space 30 Fresh air from outside is sent into the chamber space 30, and a part of the chamber space 30 is discharged by a return air device 60 that contains the mist-like medicament air.

Continuing from the above-mentioned embodiment, as shown in FIG. 2, this embodiment further includes a concentration data generating unit 70, an intake valve 71, an exhaust valve 72, a return air valve 73, and an air supply channel. The heater 50 of 40, a cooler 52 and a control module 74 arranged in the air supply channel 40, and a set of air supply devices 20 and a set of filters 51 are arranged in the air supply channel 40, and the air supply channel 40 is connected to the atomization of the medicine The device 10 is in communication to supply aerosol medicine to the air supply channel 40. In addition, the return air device 60 and another set of filters 51 are arranged in a return air passage 61, and an intake valve 71 is arranged at the end of the air supply passage 40, and an exhaust air is arranged at the end of the return air passage 61 The valve 72 is further provided with a return air valve 73 in the communication pipe 62 between the air supply passage 40 and the return air passage 61.

In the specific operation, the first step is to start the air blowing device 20 and the drug atomizing device 10, and the atomized drug is delivered to the air inlet 31 of the chamber space 30 through the air blowing device 20. At this time, the chamber can be matched. The space 30 continuously transports the mist-like medicine required for sterilization, as shown in FIG. 3. When the gas concentration value sensed by the concentration data generating unit 70 reaches the preset concentration, the control module 74 opens the return air valve 73 and the intake valve 71, and activates the return air device 60 and the air supply device 20 to make the outside fresh The air is mixed with the mist medicament and is transported into the chamber space 30 together. At the same time, the air mixed with the mist medicament inside the chamber space 30 is recovered through the return air passage 61 to recover the air and re-introduct it. In the air supply passage 40, since the air supply passage 40 is provided with a heater 50, a cooler 52, and a filter 51, the recovered air and mist-like medicine can be cooled, heated, and filter-sterilized. The mist-like medicament in the recovered air that has been used for sterilization but still remains is blown out from the air inlet 31 again, as shown in FIG. 3. When the gas concentration value sensed by the concentration data generating unit 70 exceeds the preset concentration, the control module 74 closes the medicament atomizing device 10, the intake valve 71, and the return valve. The air valve 73 and the air supply device 20 are activated, and the return air device 60 is activated and the exhaust valve 72 is opened, so that the excess mist-like medicine is discharged through the exhaust valve 72, as shown in FIG. 5. When the gas concentration value sensed by the concentration data generating unit 70 is lower than the preset concentration, return to the aforementioned first step, as shown in FIG. 2. The cooling by the cooler 52 and the heating by the heater 50 increase the temperature difference to promote the effect of disintegrating viruses and/or bacteria present in the recovered air. The filter 51 is used to filter impurities, pollutants, or dead viruses and/or bacteria in the air. After the air is purified, the mist-like agent that enters the chamber space 30 again is effective against viruses and/or bacteria. The disintegration efficiency of bacteria.

In addition, in the embodiment shown in FIG. 2, another set of medicament atomization devices 10 are arranged in the return air passage 61, so that the dose of the atomized medicament supplied can be increased. The above-mentioned concentration data generating unit 70 can be a general gas concentration sensor, a concentration parameter calculated based on the volume of the indoor space and the supply amount of aerosol medicament; or a known image recognition technology; but not based on this. limit.

In a preferred application embodiment of the present invention, the agent contains 2-(10-mercaptodecy)malonic acid (2-(10-mercaptodecy)malonic acid) or its salts; The average concentration of 2-(10-mercaptodecy)malonic acid (2-(10-mercaptodecy)malonic acid) or its salts is 50~1000ppm. It has been verified that the aforementioned agents combined with the system and method of the present invention can effectively disintegrate viruses and/or bacteria (especially coronaviruses). This new use can be quickly and effectively promoted to the isolation wards, hotel isolation rooms, isolation cabins (cruise ships, airplanes, trains, MRT carriages and cars used to accommodate people or sleep in hospitals in various countries. Isolation cabins), general rooms and isolation tents and other accommodation spaces 30) to effectively solve the serious disasters caused by the Covid-2019 virus to humans.

In a preferred application embodiment of the present invention, the mist-shaped medicament located in the chamber space 30 can be subjected to at least one specific frequency of sound and/or light and/or electric field energy waves. The energy wave At least one frequency of is 0.5 to 20000 Hz. Specifically, the energy wave may be a resonance wave. The energy wave is used to promote the disintegration efficiency of the aerosol medicine against viruses and/or bacteria.

In addition, in a preferred embodiment of the present invention, the opening and closing time of the intake valve 71, the exhaust valve 72, and the return air valve 73 can be controlled or a pressurizer can be installed to increase the air pressure in the chamber space 30 and make the chamber The air pressure P in the space 30 is higher than 1 atmospheric pressure (preferably 1<P≦3 atmospheric pressure), so the high-pressure air pressure in the chamber space 30 can promote the rapid speed between the medicine and the virus or bacteria effect.

More preferably, the present invention includes at least one electrostatic cloth layer 53, the electrostatic cloth layer 53 is used to capture viruses and/or bacteria that are or have been in the chamber space 30, and distribute the mist-like medicine for disintegration. Viruses and/or bacteria that have attached to it. The electrostatic cloth layer 53 is arranged in the chamber space 30 and/or the air supply channel 40 and/or the return air channel 61, as shown in FIG. 1 is arranged in the return air channel 61.

Furthermore, it must be clarified that the application agent prepared by the Republic of China Invention Patent No. I488661 can partially destroy the nanostructure of the SARS virus. At the same time, it is found that less than 40% of the SARS virus has a "corona spike" within 5 minutes. "It was disintegrated and stripped. According to the inventor’s research, it can be reasonably inferred that after mixing a medicament made of 2-(10-mercaptodecy)malonic acid (2-(10-mercaptodecy)malonic acid) or its salts with an aqueous solution, Then use the medicine atomizing device 10 to atomize the medicine into aerosol medicine, and then transport it into the chamber space 30 through the air supply channel 40, so that the aerosol medicine in the chamber space 30 can be retained to inhibit the disintegration of the 2019-nCoV novel Coronavirus, not only that, but also against deadly viruses such as H1N1, H5N1, Ev71 enterovirus 71 and HPV cervical cancer virus. The remaining forces can be resurrected from the dead.

The 2-(10-mercaptodecy)malonic acid of the present invention (2-(10-mercaptodecy)malonic acid) or its salt medicament has been found to be enhanced after experimental testing of various viruses and bacteria. The Center for Disease Control and Prevention" and the British SGS dual test report, concurrently issued Now it can easily destroy the more complex and compact structure of bacteria, Candida albicans, Pseudomonas aeruginosa and Staphylococcus aureus, etc., and surprisingly, it can achieve 99.56%~100% sterilization effect. In addition, after the first case of super bacteria entered Taiwan, Dr. Lai Xinzhi from Chang Gung Memorial Hospital found that 2-(10-mercaptodecy)malonic acid (2-(10-mercaptodecy)malonic acid) or its salts can be used to successfully disrupt the super bacteria. The structure of super bacteria quickly and powerfully interrupts the steel beam and steel column structure of viruses and difficult bacteria within a few minutes.

The principle inference of the present invention for disintegrating 2019-nCoV novel coronavirus is that spraying a mist-like agent in the indoor space 30 to form a barrier in the indoor space 30. When viruses and bacteria come into contact with the 2-(10-Hydroxysulfide) of the present invention Decyl) malonic acid (2-(10-mercaptodecy)malonic acid) or its salt mist forms, it will begin to collapse. Taking the H1N1 particles of influenza A virus as an example, the 2-( After 10-mercaptodecy)malonic acid (2-(10-mercaptodecy)malonic acid) or its salts, it collapsed from the original height of about 54 nanometers to about 5 nanometers. It has been verified by mechanics. After it is effective, it is confirmed through virological experiments that all have lost the ability to infect and multiply. Obviously, 2-(10-mercaptodecy)malonic acid (2-(10-mercaptodecy)malonic acid) or its salts are molecular enzymes that have both oxidation and reduction capabilities.

In summary, the 2-(10-mercaptodecy)malonic acid (2-(10-mercaptodecy)malonic acid) or its salt medicament of the present invention does have the effects of biofilm inhibition and poisoning, and it will have the effect in the future It is extremely developmental and can contribute to the well-being of mankind, so as to eliminate the major harm to the lives, economic development, medical system and the psychological level of the people caused by the new coronavirus in the shortest time.

The above are only feasible embodiments of the present invention, and are not intended to limit the scope of patent of the present invention. Anything based on the content, features and spirit of the following claims The equivalent implementation for other changes should be included in the scope of the patent of the present invention. The structural features of the invention specifically defined in the claim are not found in similar articles, and are practical and progressive. They have already met the requirements of a patent for invention. The application is filed in accordance with the law. I would like to request that the Bureau of Junction approve the patent in accordance with the law to protect this The legitimate rights and interests of the applicant.

10: Medicament atomization device

20: Air supply device

30: Room space

31: Air inlet

40: Air supply channel

50: heater

51: filter

52: cooler

53: Electrostatic cloth layer

60: Return air device

61: Return air channel

71: intake valve

72: exhaust valve

73: Return air valve

Claims (10)

A method for inhibiting the disintegration of virus and bacteria in a compartment space, which comprises the following steps: Atomizing the medicament into a mist-like medicament with at least one medicament atomizing device; At least one air supply device is used to transport and supply the aerosolized medicament atomized by the at least one medicament atomization device into a chamber space through at least one air supply channel; and The aerosol medicine in the chamber space disintegrates the viruses and/or bacteria present in the chamber space. The method according to claim 1, wherein the at least one air inlet of the at least one air supply channel connected to the chamber space is within 4 meters from the position where the at least one patient in the chamber space is located for a long time. The method according to claim 1, wherein a plurality of nozzles arranged in a row on at least one duct of the at least one air supply channel are used to deliver the mist-like medicament into the chamber space to form at least one medicament mist screen, so that the at least A medicine mist curtain surrounds at least one side of at least one patient in the chamber space. The method according to claim 1, wherein when the mist-like medicament in the chamber space reaches a predetermined concentration, it is controlled to continuously supply the mist-like medicament to the chamber space, and the air supply device will be located in the chamber space The new air outside is sent into the chamber space, and a part of the chamber space is mixed with the air containing the mist-like medicament to be discharged from the chamber space by a return air device. The method according to claim 4, wherein the new air located outside the chamber space is heated by at least one heater and filtered by at least one filter, and then mixed with the mist-like medicament to be sent into the chamber space. The method according to claim 4, wherein at least one filter of the return air device is used to filter the part of the air mixed with the mist-like medicament discharged from the chamber space to recover the air, and mix the recovered air to The fresh air is sent into the chamber space by the air blowing device. The method according to claim 1, wherein the medicament contains 2-(10-mercaptodecy)malonic acid (2-(10-mercaptodecy)malonic acid) or a salt thereof; in the chamber space The average concentration of 2-(10-mercaptodecy)malonic acid (2-(10-mercaptodecy)malonic acid) or its salts is 50~1000ppm. The method according to claim 1, wherein the mist-like medicament located in the chamber space is subjected to at least one specific frequency sound and/or light and/or electric field energy wave; the at least one electric field energy wave The frequency is 0.5~20000Hz. A room space virus and bacteria disintegration inhibition system, which includes: At least one medicament atomization device for atomizing the medicament into a mist-like medicament; and At least one air supply device for conveying and supplying the aerosol medicament atomized by the at least one medicament atomization device into a chamber space through at least one air supply channel; the mist medicament in the chamber space disintegrates and exists Viruses and/or bacteria in the chamber space. The system according to claim 9, wherein a plurality of nozzles arranged in a row on at least one duct of the at least one air supply channel deliver the mist-like medicine into the chamber space to form at least one medicine mist curtain, so that the at least one medicine mist screen The medicine mist curtain surrounds at least one side of at least one patient in the chamber space; when the mist medicine in the chamber space reaches a predetermined concentration, control the continuous supply of mist medicine to the chamber space, and The air supply device sends new air outside the chamber space into the chamber space, and uses a return air device to discharge part of the chamber space mixed with mist-like medicament air out of the chamber space; At least one electrostatic cloth layer, which is used to capture viruses and/or bacteria that are located or used to be in the chamber space, and is used for the spraying of aerosol medicine to disintegrate the viruses and/or bacteria that have been attached to it .

Images